Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy

1. Y. Kwon, Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy, OncoTargets Ther.9 (2016) 2007–2016; https://doi.org/10.2147/OTT.S9689910.2147/OTT.S96899482789427103826Search in Google Scholar

2. B. Lončar Brzak and M. Mravak Stipetić, Scales for the assessment of oral mucositis, Medix20 (2014) 213–216.10.1155/2014/746874Search in Google Scholar

3. M. Muhvić Urek, I. Glažar, A. Braut, and S. Pezelj-Ribarić, Radiation induced oral mucositis – therapeutic strategy in a case report, Med. Flum.51 (2015) 310–317.Search in Google Scholar

4. D. I. Rosenthal and A. Trotti, Strategies for managing radiation-induced mucositis in head and neck cancer, Semin. Radiat. Oncol.19 (2009) 29–34; https://doi.org/10.1016/j.semradonc.2008.09.00610.1016/j.semradonc.2008.09.00619028343Search in Google Scholar

5. P. Franco, S. Martini, J. Di Muzio, C. Cavallin, F. Arcadipane, M. Rampino, O. Ostellino, G. Pecorari, P. G. Demo, M. Fasolis and M. Airoldi, Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer, Med. Oncol.34 (2017) 81; https://doi.org/10.1007/s12032-017-0950-110.1007/s12032-017-0950-128386836Search in Google Scholar

6. R. V. Lalla, S. T. Sonis and D. E. Peterson, Management of oral mucositis in patients who have cancer, Dent. Clin. North Am. 52 (2008) 61–77; https://doi.org/10.1016/j.cden.2007.10.00210.1016/j.cden.2007.10.002226683518154865Search in Google Scholar

7. D. B. McGuire, M. E. P. Correa, J. Johnson and P. Wienandts, The role of basic oral care and good clinical practice principles in the management of oral mucositis, Support. Care Cancer14 (2006) 541–547; https://doi.org/10.1007/s00520-006-0051-810.1007/s00520-006-0051-816775649Search in Google Scholar

8. J. A. Kushner, H. P. Lawrence, I. Shoval, T. L. Kiss, G. M. Devins, L. Lee and H. C. Tenenbaum, Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale, J. Can. Dent. Assoc.74 (2008) 59a-59j; http://www.cda-adc.ca/jcda/vol-74/issue-1/59.pdfSearch in Google Scholar

9. A. Shankar, S. Roy, M. Bhandari, G. K. Rath, A. S. Biswas, R. Kanodia, N. Adhikari and R. Sachan, Current trends in management of oral mucositis in cancer treatment, Asian Pac. J. Cancer Prev.18 (2017) 2019–2026; https://doi.org/10.22034/APJCP.2017.18.8.2019Search in Google Scholar

10. Y. Shao and H. Zhou, Clinical evaluation of a toothpaste containing lysozyme for the treatment of recurrent aphthous stomatitis: A 3-month, double-blind, randomized study, Am. J. Dent. 29 (2016) 303–306.Search in Google Scholar

11. S. A. Ragland and A. K. Criss, From bacterial killing to immune modulation: Recent insights into the functions of lysozyme, PLoS Pathog.13 (2017) e1006512; https://doi.org/10.1371/journal.ppat.100651210.1371/journal.ppat.1006512560840028934357Search in Google Scholar

12. T. G. Villa and P. V. Crespo, Enzybiotics: Antibiotic enzymes as drugs and therapeutics, Wiley. Com. 2010. (Online); https://www.wiley.com/en-rs/Enzybiotics%3A+Antibiotic+Enzymes+as+Drugs+and+Therapeutics-p-9780470570531 (last access November 20, 2018).10.1002/9780470570548Search in Google Scholar

13. F. T. Károly, P. Hermann, A. Beck, P. Fejérdy and G. Fábián, Salivary defense proteins: their network and role in innate and acquired oral immunity, Int. J. Mol. Sci.13 (2012) 4295–4320; https://doi.org/10.3390/ijms1304429510.3390/ijms13044295334421522605979Search in Google Scholar

14. T. Catic, M. Mehic, A. Lokvancic and B. Kapo, Lysozyme – enzybiotic as a potential solution of the global problem of antibiotic resistance, Farm. Glas.73 (2017) 273–288.Search in Google Scholar

15. I. Dozić and T. Todorović, Antimicrobial proteins of human saliva, Serbian Dent. J.52 (2005) 208–216; https://scindeks-clanci.ceon.rs/data/pdf/0039-1743/2005/0039-17430504208D.pdf10.2298/SGS0504208DSearch in Google Scholar

16. E. Gajda and G. Bugla-Płoskońska, Lysozyme-occurrence in nature, biological properties and possible applications, Postepy Hig. Med. Doswiadczalnej Online68 (2014) 1501–1515; https://doi.org/10.5604/17322693.113310010.5604/17322693.113310025531714Search in Google Scholar

17. M. Derde, V. Vié, A. Walrant, S. Sagan, V. Lechevalier, C. Guérin-Dubiard, S. Pezennec, M. F. Cochet, G. Paboeuf, M. Pasco and F. Baron, Antimicrobial activity of lysozyme isoforms: Key molecular features, Biopolymers107 (2017); https://doi.org/10.1002/bip.2304010.1002/bip.2304028944959Search in Google Scholar

18. Y. H. Samaranayake, B. P. Cheung, N. Parahitiyawa, C. J. Seneviratne, J. Y. Yau, K. W. Yeung and L. P. Samaranayake, Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces, Arch. Oral Biol.54 (2009) 115–126; https://doi.org/10.1016/j.archoralbio.2008.09.01510.1016/j.archoralbio.2008.09.01519038377Search in Google Scholar

19. E. Karolewska, T. Konopka, M. Pupek, A. Chybicka and M. Mendak, Antibacterial potential of saliva in children with leukemia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.105 (2008) 739–744; https://doi.org/10.1016/j.tripleo.2007.10.01010.1016/j.tripleo.2007.10.01018329914Search in Google Scholar

20. T. Sobue, M. Bertolini, A. Thompson, D. E. Peterson, P. I. Diaz and A. Dongari-Bagtzoglou, Chemotherapy-induced oral mucositis and associated infections in a novel organotypic model, Mol. Oral Microbiol.33 (2018) 212–223; https://doi.org/10.1111/omi.1221410.1111/omi.12214594531929314782Search in Google Scholar

21. S. Raj, D. Sharma, P. Mate, M. R. Capoor and K. T. Bhowmik. A study of changes in the oral fungal flora of patients on radiotherapy for head and neck malignancies and their correlation with funguria and fungemia, Indian. J. Cancer. 54 (2017) 39–42; https://doi.org/10.4103/ijc.IJC_155_1710.4103/ijc.IJC_155_1729199660Search in Google Scholar

22. H. R. Ibrahim, K. Hamasaki and T. Miyata, Novel peptide motifs from lysozyme suppress pro-inflammatory cytokines in macrophages by antagonizing toll-like receptor and LPS-scavenging action, Eur. J. Pharm. Sci.107 (2017) 240–248; https://doi.org/10.1016/j.ejps.2017.07.00510.1016/j.ejps.2017.07.00528711715Search in Google Scholar